Your browser doesn't support javascript.
loading
Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity.
Younes, Ahmed I; Barsoumian, Hampartsoum B; Sezen, Duygu; Verma, Vivek; Patel, Roshal; Wasley, Mark; Hu, Yun; Dunn, Joe D; He, Kewen; Chen, Dawei; Menon, Hari; Masrorpour, Fatemeh; Gu, Meidi; Yang, Liangpeng; Puebla-Osorio, Nahum; Cortez, Maria Angelica; Welsh, James W.
Afiliação
  • Younes AI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Barsoumian HB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sezen D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Verma V; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Patel R; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wasley M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hu Y; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Dunn JD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • He K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, China.
  • Chen D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, China.
  • Menon H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Radiation Oncology, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.
  • Masrorpour F; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gu M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yang L; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Puebla-Osorio N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Cortez MA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Welsh JW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jwelsh@mdanderson.org.
Transl Oncol ; 14(2): 100983, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33340886
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article